The market just doesn't like risk at the moment. This is a huge change from the pre covid era. Back then, companies like CHM would be flying (look at IMU and OPT charts from back then). Now, adversion to risk means companies are kept on watch lists and not touched until a properly confirmed breakout occurs. When that happens, they run hard.
We are lucky that liquidity has improved. This has helped soften some of the bumps.
Hopefully a fast track approval pathway application for GBM once the 1b trial is completed. And we only need results to keep replicating what has been already achieved to be successful with that. And then we have the other 3 trials!
Lots to like here.
The market just doesn't like risk at the moment. This is a...
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $23.12M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.7¢ | $11.23K | 416K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 82560 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 255000 | 2 |
View Market Depth
| Last trade - 14.08pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.7¢ |
Change
0.001 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 2.7¢ | 2.7¢ | 2.7¢ | 17440 | ||
| Last updated 14.55pm 10/05/2024 ? | |||||
| CHM (ASX) Chart |